Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volume: 76

Issue: 6

Year of Publication: 2023

Affiliated Institutions:  Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA. Infectious Diseases Institute, Makerere University, Kampala, Uganda. Cancer Data Registry of Idaho, Idaho Hospital Association, Boise, Idaho, USA. Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda. Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA. Weill Institute of Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, California, USA. Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Abstract summary 

Cryptococcal meningitis is a common cause of AIDS-related mortality. Although symptom recurrence after initial treatment is common, the etiology is often difficult to decipher. We sought to summarize characteristics, etiologies, and outcomes among persons with second-episode symptomatic recurrence.We prospectively enrolled Ugandans with cryptococcal meningitis and obtained patient characteristics, antiretroviral therapy (ART) and cryptococcosis histories, clinical outcomes, and cerebrospinal fluid (CSF) analysis results. We independently adjudicated cases of second-episode meningitis to categorize patients as (1) microbiological relapse, (2) paradoxical immune reconstitution inflammatory syndrome (IRIS), (3) persistent elevated intracranial pressure (ICP) only, or (4) persistent symptoms only, along with controls of primary cryptococcal meningitis. We compared groups with chi-square or Kruskal-Wallis tests as appropriate.724 participants were included (n = 607 primary episode, 81 relapse, 28 paradoxical IRIS, 2 persistently elevated ICP, 6 persistent symptoms). Participants with culture-positive relapse had lower CD4 (25 cells/μL; IQR: 9-76) and lower CSF white blood cell (WBC; 4 cells/μL; IQR: 4-85) counts than paradoxical IRIS (CD4: 78 cells/μL; IQR: 47-142; WBC: 45 cells/μL; IQR: 8-128). Among those with CSF WBC <5 cells/μL, 86% (43/50) had relapse. Among those with CD4 counts <50 cells/μL, 91% (39/43) had relapse. Eighteen-week mortality (from current symptom onset) was 47% among first episodes of cryptococcal meningitis, 31% in culture-positive relapses, and 14% in paradoxical IRIS.Poor immune reconstitution was noted more often in relapse than IRIS as evidenced by lower CSF WBC and blood CD4 counts. These easily obtained laboratory values should prompt initiation of antifungal treatment while awaiting culture results.NCT01802385.

Authors & Co-authors:  Bahr Nathan C NC Skipper Caleb P CP Huppler-Hullsiek Kathy K Ssebambulidde Kenneth K Morawski Bozena M BM Engen Nicole W NW Nuwagira Edwin E Quinn Carson M CM Ramachandran Prashanth S PS Evans Emily E EE Lofgren Sarah M SM Abassi Mahsa M Muzoora Conrad C Wilson Michael R MR Meya David B DB Rhein Joshua J Boulware David R DR

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Rajasingham R, Govender NP, Jordan A, et al. . The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis [manuscript published online ahead of print 29 August 2022]. Lancet Infect Dis.
Authors :  17
Identifiers
Doi : 10.1093/cid/ciac853
SSN : 1537-6591
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
cryptococcal meningitis;cryptococcosis;immune reconstitution inflammatory syndrome;meningitis;relapse
Study Design
Cross Sectional Study
Study Approach
Country of Study
Uganda
Publication Country
United States